Clinical Trial Update: A Study of FOLFOX6 With Bevacizumab for Biliary System Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating FOLFOX6 with Bevacizumab for biliary tract cancer was terminated; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Bevacizumab (bevacizumab)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Georgetown University | Conditions: Biliary Tract Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-10-20